Literature DB >> 15583102

Clinical features of patients with Kawasaki disease whose parents had the same disease.

Ritei Uehara1, Mayumi Yashiro, Yosikazu Nakamura, Hiroshi Yanagawa.   

Abstract

OBJECTIVE: To observe the clinical characteristics of patients with Kawasaki disease whose parent also had the same disorder.
DESIGN: Cross-sectional study using the data from nationwide surveys of Kawasaki disease in Japan.
SETTING: All hospitals with a bed capacity of 100 or more and pediatric departments in Japan. PATIENTS: All patients described on the 16th and 17th surveys covering the 4-year period from January 1, 1999, through December 31, 2002. MAIN OUTCOME MEASURES: We compared clinical details, including sibling case, recurrence, diagnosis, administration of intravenous immunoglobulin, and coronary abnormalities, between patients whose parents had Kawasaki disease and patients with no parental history of Kawasaki disease. We also observed age at onset and sex of affected parent-offspring pairs with Kawasaki disease confirmed by using the data of previous nationwide surveys.
RESULTS: The odds for having sibling cases were significantly increased among patients whose parents also had Kawasaki disease (odds ratio, 6.94; 95% confidence interval, 2.77-17.38). Patients with parental Kawasaki disease were more likely to experience recurrent Kawasaki disease, receive additional administration of intravenous immunoglobulin, and experience coronary abnormalities at 1 month after onset. Among confirmed parent-offspring pairs with Kawasaki disease, the mean age at onset of offspring was younger than that of their parents (25.6 vs 41.8 months), despite the lack of statistical significance.
CONCLUSIONS: Some cases of Kawasaki disease show familial susceptibility to the disorder. Family history, especially parental history of Kawasaki disease, may be an indicator of disease severity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15583102     DOI: 10.1001/archpedi.158.12.1166

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  9 in total

1.  Familial occurrence of Kawasaki syndrome in North America.

Authors:  Marina Dergun; Annie Kao; Sarmistha B Hauger; Jane W Newburger; Jane C Burns
Journal:  Arch Pediatr Adolesc Med       Date:  2005-09

2.  Transforming growth factor beta receptor II polymorphisms are associated with Kawasaki disease.

Authors:  Yu Mi Choi; Kye Sik Shim; Kyung Lim Yoon; Mi Young Han; Sung Ho Cha; Su Kang Kim; Joo Ho Jung
Journal:  Korean J Pediatr       Date:  2012-01-31

3.  Variations in ORAI1 Gene Associated with Kawasaki Disease.

Authors:  Yoshihiro Onouchi; Ryuji Fukazawa; Kenichiro Yamamura; Hiroyuki Suzuki; Nobuyuki Kakimoto; Tomohiro Suenaga; Takashi Takeuchi; Hiromichi Hamada; Takafumi Honda; Kumi Yasukawa; Masaru Terai; Ryota Ebata; Kouji Higashi; Tsutomu Saji; Yasushi Kemmotsu; Shinichi Takatsuki; Kazunobu Ouchi; Fumio Kishi; Tetsushi Yoshikawa; Toshiro Nagai; Kunihiro Hamamoto; Yoshitake Sato; Akihito Honda; Hironobu Kobayashi; Junichi Sato; Shoichi Shibuta; Masakazu Miyawaki; Ko Oishi; Hironobu Yamaga; Noriyuki Aoyagi; Megumi Yoshiyama; Ritsuko Miyashita; Yuji Murata; Akihiro Fujino; Kouichi Ozaki; Tomisaku Kawasaki; Jun Abe; Mitsuru Seki; Tohru Kobayashi; Hirokazu Arakawa; Shunichi Ogawa; Toshiro Hara; Akira Hata; Toshihiro Tanaka
Journal:  PLoS One       Date:  2016-01-20       Impact factor: 3.240

4.  Major methylation alterations on the CpG markers of inflammatory immune associated genes after IVIG treatment in Kawasaki disease.

Authors:  Sung-Chou Li; Wen-Ching Chan; Ying-Hsien Huang; Mindy Ming-Huey Guo; Hong-Ren Yu; Fu-Chen Huang; Hsing-Chun Kuo; Ho-Chang Kuo
Journal:  BMC Med Genomics       Date:  2016-08-12       Impact factor: 3.063

5.  Innate immune responses following Kawasaki disease and toxic shock syndrome.

Authors:  Katherine Y H Chen; Nicole Messina; Susie Germano; Rhian Bonnici; Bridget Freyne; Michael Cheung; Greta Goldsmith; Tobias R Kollmann; Michael Levin; David Burgner; Nigel Curtis
Journal:  PLoS One       Date:  2018-02-15       Impact factor: 3.240

6.  Kawasaki disease patients homozygous for the rs12252-C variant of interferon-induced transmembrane protein-3 are significantly more likely to develop coronary artery lesions.

Authors:  Neil E Bowles; Cammon B Arrington; Keiichi Hirono; Tsuneyuki Nakamura; Long Ngo; Yin Shen Wee; Fukiko Ichida; John H Weis
Journal:  Mol Genet Genomic Med       Date:  2014-05-14       Impact factor: 2.183

7.  High-density genotyping of immune loci in Kawasaki disease and IVIG treatment response in European-American case-parent trio study.

Authors:  A Shendre; H W Wiener; D Zhi; A I Vazquez; M A Portman; S Shrestha
Journal:  Genes Immun       Date:  2014-08-07       Impact factor: 2.676

Review 8.  Recent Advances in Kawasaki Disease.

Authors:  Kyu Yeun Kim; Dong Soo Kim
Journal:  Yonsei Med J       Date:  2016-01       Impact factor: 2.759

Review 9.  Kawasaki Disease: an Update.

Authors:  Eileen Rife; Abraham Gedalia
Journal:  Curr Rheumatol Rep       Date:  2020-09-13       Impact factor: 4.592

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.